Moreover, we explore the survival probability of neuroblastoma patients among these relevant genes through the PCAT (PDX for childhood cancer Therapeutics http://pedtranscriptome.org/?home), in which the statistical analysis (Figure 2) shows that ALKBH1 level is negatively correlated with the survival probability of neuroblastoma patients. Here, ALKBH1 is linked to childhood malignant neoplasm.